Results showed that FGD5-AS1 expression level is not significantly different in normal vs cancer tissues and in luminal-like (MCF-7, T-47D and ZR-75-1), triple negative (MDA-MB-231 and Hs-578T) BC and immortalized epithelial (MCF-10A) breast cell lines. This evidence concerns the gene FGD5 and breast cancer.